Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG (pH4) vs comparator in ITP
CTR20150764Phase 3Completed
- Sponsor
- Hebei Da'an Pharmaceutical
- Start
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of intravenous human immunoglobulin (pH4) in immune thrombocytopenia (ITP), sponsored by Hebei Da'an Pharmaceutical. Started Jan 2016; status: completed.
02
Drugs
intravenous human immunoglobulin (pH4)
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on CTR20150764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150764.